ArticleBiomedicines2021

Hydroxycoumarin Scopoletin Inhibits Bone Loss through Enhancing Induction of Bone Turnover Markers in a Mouse Model of Type 2 Diabetes.

Eun-Jung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.